SCHEMBL24180218

SCHEMBL24180218

CCCc1cc(F)ccc1OCC(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 5/20 0.40
▸ PPARD Q03181 4/20 0.40
▸ PPARA Q07869 4/20 0.40
▸ NTRK1 P04629 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ HSP90AB1 P08238 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ G6PD P11413 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MRGPRX1 Q96LB2 2/20 0.39
▸ HMGCR P04035 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24180069 0.81 AR (0.47) PPARDALDH1A1KDM4EMEN1USP2
SCHEMBL22390440 0.81 NTRK1 (0.40) NTRK1ALDH1A1KDM4EMEN1USP2
SCHEMBL3291252 0.80 MAPT (0.46) NTRK1ALDH1A1KDM4EMEN1USP2
SCHEMBL22957698 0.79 SLC6A4 (0.56) NTRK1ALDH1A1
SCHEMBL12844526 0.79 HMGCR (0.53) KDM4EHMGCRGABRA1GABRB2
SCHEMBL22957928 0.77 NTRK1 (0.41) NTRK1ALDH1A1KDM4EMEN1USP2
SCHEMBL14409249 0.76 SSTR4 (0.46) ALDH1A1KDM4EMEN1USP2HSP90AA1
SCHEMBL22957691 0.76 NTRK1 (0.44) NTRK1ALDH1A1MRGPRX1RAB9ACYP1A2
SCHEMBL22957708 0.76 NTRK1 (0.42) NTRK1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL16797594 0.75 HTR1A (0.53) ALDH1A1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3704118-B1 AMINOIMIDAZOPYRIDAZINES AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2022-01-12 — — EP disclosed
Send feedback